Quickfind
Show latest about:
Sector
Topic
Keep settings
  Freetext search
 Home
 News
 Analysis
 Features
 Market prices
 Technology guide
 Real estate
 Israel in depth
RSS  feeds
  Search results
News
Teva receives US clearance for Actavis acquisition
With regulatory approval, the Israeli pharmaceutical company will complete the $40 billion acquisition next week.
Globes correspondent   28 Jul 16   06:33

Teva mulls buying Pfizer's Brazilian venture - report
Teuto|Pfizer would expand Teva limited presence in the Brazilian market, "Reuters" reports.
Shiri Habib-Valdhorn   27 Jul 16   15:03

Exalenz Bioscience raises NIS 23.5m in TASE offering
Mori Arkin is the main backer of the Israeli company, which diagnoses congestive conditions from exhaled breath.
Gali Weinreb   25 Jul 16   14:09

DreaMed Diabetes raises $3.3m from Roman Abramovich
The funds will be used to develop the Israeli company's decision support technology platform for optimal insulin treatment plans.
Globes correspondent    25 Jul 16   13:50

Medical Compression announces 30% layoffs
Gali Weinreb   24 Jul 16   18:21

Israeli drug developer Entera Bio raises $7.5m
Gali Weinreb   24 Jul 16   15:06

UK funding Israel-Arab research programs
Gali Weinreb   22 Jul 16   10:44

Teva raises 1b Swiss francs in debt
Globes correspondent   22 Jul 16   10:39

Teva raises €4b in European bond offering
Globes correspondent    21 Jul 16   09:06

Israel's Trendlines to set up Singapore medtech incubator
Gali Weinreb   20 Jul 16   17:37

Hospital dept heads to be barred from private practice
Shay Niv   19 Jul 16   14:50

Bladder treatment co Vensica raises $500,000
Globes correspondent   19 Jul 16   12:06

BrainStorm stem cell treatment succeeds in ALS trial
Gali Weinreb   19 Jul 16   11:35

Teva raises $15b debt
Globes correspondent   19 Jul 16   09:36

Features
Rosario capital sees RedHill breakthrough
The annual market sales potential of RedHill's molecules is worth hundreds of millions of dollars, says Rosario Capital.
Zeev Zak   12 Jul 16   16:23

"Our triangular implant leaves more room for bone"
MIS CEO Idan Kleifeld tells "Globes" that the Karmiel company will remain a separate unit after its $375 million acquisition by Dentsply.
Gali Weinreb   28 Jun 16   19:25

Steba offers prostate cancer patients a better approach
With its combination medicine and medical device invented at the Weizmann Institute, a father-son team aims to provide a more efficient treatment.
Gali Weinreb   20 Jun 16   15:03

Teva stands behind Allergan price
Shiri Habib-Valdhorn    9 Jun 16   19:02

Israeli co brings gynecology into the 21st century
Gali Weinreb    9 Jun 16   10:37

"Our investors are aware of Israeli capabilities"
Gali Weinreb   24 May 16   14:26